News | 07 August 2012
7, 2012 (GLOBE NEWSWIRE) -- Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX) , a specialty pharmaceutical company, today reported its financial results for the second quarter ended June 30, 2012. "Since the beginning of the second quarter of 2012, we ...
Click on the link to read the full article at MarketWatch (press release)
(This link will open in a new window)